Skip to content
10-Q

Quarterly Report

SOLENO THERAPEUTICS INC

0001193125-25-264941

← back to feed
Filed
Nov 4, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Long Term Debt Q3 2025 · Dec 31, 2025 $49.83M
Long Term Debt Q3 2025 · Sep 30, 2025 $49.85M
Long Term Debt Q3 2025 · Dec 31, 2024 $49.83M
Shares Outstanding Q3 2025 · Oct 31, 2025 53.71M sh
Shares Diluted Q3 2025 · Sep 30, 2025 54.92M sh
Shares Diluted Q3 2025 · Sep 30, 2025 50.02M sh
Shares Diluted Q3 2025 · Sep 30, 2024 41.88M sh
Shares Diluted Q3 2025 · Sep 30, 2024 38.92M sh
Capex Q3 2025 · Sep 30, 2025 $15K
Capex Q3 2025 · Sep 30, 2024 $210K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$1.91M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$45.11M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $246.66M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $87.93M
Stockholders Equity Q3 2025 · Sep 30, 2025 $494.81M
Stockholders Equity Q3 2025 · Jun 30, 2025 $240.14M
Stockholders Equity Q3 2025 · Mar 31, 2025 $232.26M
Stockholders Equity Q3 2025 · Dec 31, 2024 $245.11M
Stockholders Equity Q3 2025 · Sep 30, 2024 $264.7M
Stockholders Equity Q3 2025 · Jun 30, 2024 $280.76M
Stockholders Equity Q3 2025 · Mar 31, 2024 $143.39M
Stockholders Equity Q3 2025 · Dec 31, 2023 $157.51M
Current Liabilities Q3 2025 · Sep 30, 2025 $33.25M
Current Liabilities Q3 2025 · Dec 31, 2024 $18.75M
Total Liabilities Q3 2025 · Sep 30, 2025 $105.09M
Total Liabilities Q3 2025 · Dec 31, 2024 $85.86M
Current Assets Q3 2025 · Sep 30, 2025 $534.85M
Current Assets Q3 2025 · Dec 31, 2024 $293.89M
Total Assets Q3 2025 · Sep 30, 2025 $599.9M
Total Assets Q3 2025 · Dec 31, 2024 $330.97M
Eps Diluted Q3 2025 · Sep 30, 2025 $0.47
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.45
Eps Diluted Q3 2025 · Sep 30, 2024 −$1.83
Eps Diluted Q3 2025 · Sep 30, 2024 −$3.08
Eps Basic Q3 2025 · Sep 30, 2025 $0.49
Eps Basic Q3 2025 · Sep 30, 2025 −$0.45
Eps Basic Q3 2025 · Sep 30, 2024 −$1.83
Eps Basic Q3 2025 · Sep 30, 2024 −$3.08
Sga Expense Q3 2025 · Sep 30, 2025 $33.75M
Sga Expense Q3 2025 · Sep 30, 2025 $91.25M
Sga Expense Q3 2025 · Sep 30, 2024 $49.2M
Sga Expense Q3 2025 · Sep 30, 2024 $68.56M
Rd Expense Q3 2025 · Sep 30, 2025 $8.41M
Rd Expense Q3 2025 · Sep 30, 2025 $31.07M
Rd Expense Q3 2025 · Sep 30, 2024 $30.14M
Rd Expense Q3 2025 · Sep 30, 2024 $57.08M
Net Income Q3 2025 · Sep 30, 2025 $26.01M
Net Income Q3 2025 · Sep 30, 2025 −$22.47M
Net Income Q3 2025 · Jun 30, 2025 −$4.71M
Net Income Q3 2025 · Mar 31, 2025 −$43.77M
Net Income Q3 2025 · Sep 30, 2024 −$76.62M
Net Income Q3 2025 · Sep 30, 2024 −$119.87M
Net Income Q3 2025 · Jun 30, 2024 −$21.85M
Net Income Q3 2025 · Mar 31, 2024 −$21.4M
Operating Income Q3 2025 · Sep 30, 2025 $22.11M
Operating Income Q3 2025 · Sep 30, 2025 −$30.16M
Operating Income Q3 2025 · Sep 30, 2024 −$80.21M
Operating Income Q3 2025 · Sep 30, 2024 −$128.56M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $1.14M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $1.84M